ECM Archives - Page 10 of 15 - Bryan, Garnier & Co

Oryzon tombstone

Bryan, Garnier & Co acts as Joint Bookrunner of a private placement with US and European Investors raising €18 Million for Oryzon

Symetis tombstone

Upon pricing its landmark IPO on Euronext Paris led by Sole Global Coordinator Bryan, Garnier & Co, Symetis is acquired by Boston Scientific for USD 435 million

Zealand tombstone

Bryan, Garnier & Co announces the successful USD 22 million / DKK 143 million follow-on offering for Zealand Pharma

Soitec tombstone

Bryan, Garnier & Co annouces the successful closing of Soitec’s €75.4 million Rights Issue

Sandes Sparebank_jun16

Rights Issue Sandnes Sparebank ASA

Amoeba tombstone

Bryan, Garnier & Co announces a €14.7m follow-on offering for Amoeba on Euronext with demand from European and US investors

GeNeuro tombstone

Bryan Garnier & Co advises GeNeuro on its Euronext IPO, raising €33 million, acting as Global Coordinator & Joint Bookrunner

SparebankenVest_tombstone_dec15

Equity Issue SparebankenVest AS

DBV Technologies tombstone

Bryan Garnier & Co advises DBV Technologies on its follow-on offering, raising $281.5m in July 2015, acting as financial advisor

Amoéba 2015

Bryan, Garnier & Co announces the successful €13.2m Euronext IPO of Amoéba

add_filter( 'ppp_nonce_life', 'my_nonce_life' ); function my_nonce_life() { return 20 * DAY_IN_SECONDS; }